Tag: Sexually Transmitted Diseases: AIDS/HIV
Neural Tube Defect Prevalence 7.0 Per 10,000 in HIV-Exposed
Prevalence of 7.0 per 10,000 HIV-exposed pregnancies similar to prevalence in general population
Early Antiretroviral Therapy May Not Achieve HIV Remission in Infants
Similar proportion of infants attain, sustain viral suppression when starting <48 hours, two to 14 days after birth
HIV+ Patients Lose Immunity to Smallpox Despite Vaccination
Among HIV+ patients, there was a significant loss in vaccinia-specific CD4+ T cell memory
December 2019 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for December 2019. This roundup includes...
Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART
Antiretroviral Prescribing in Pregnancy Strays From National Guidelines
Many prescribed ARVs with insufficient evidence, not recommended for use in pregnant women with HIV
Facebook Asked to Remove ‘Factually Inaccurate’ Ads About PrEP
Ads are from law firms seeking litigants for class-action lawsuit against Truvada maker Gilead Sciences
Cost Saving-Related Rx Nonadherence Found for 7 Percent With HIV
Persons nonadherent due to cost more likely to have visited ED, been hospitalized, not be virally suppressed
New HIV Infections Remained Stable in U.S. From 2013 to 2017
Of the 1.2 million people with indications for PrEP in 2018, only 18.1 percent had been prescribed PrEP
New Federal Program Provides Free HIV Prevention Drugs to Uninsured
Expanding access to PrEP is key part of government's aim of ending nation's HIV epidemic by 2030
